Literature DB >> 29953935

Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence.

Ann-Kathrin Stock1, Marion Rädle2, Christian Beste2.   

Abstract

Chronic heavy methamphetamine use likely causes dopaminergic neurotoxicity, which is commonly thought to result in cognitive control deficits. Both of these alterations may persist even after the use is discontinued, but tend to (partly) improve with increasing duration of abstinence. While several studies have demonstrated that the reinstatement of comparatively normal dopaminergic signaling may take months, if not years, the amelioration of cognitive deficits has predominantly been investigated in much shorter intervals of several weeks to less than half a year. Against this background, we set out to investigate the effects on prolonged abstinence in n = 27 abstinent former methamphetamine users in a cross-sectional design using behavioral and neurophysiological measures of cognitive control. Our behavioral results suggest that former users struggled to identify and adapt to different degrees of cognitive control requirements, which made their behavioral performance less expedient than that of healthy controls. On the neurophysiological level, this was reflected by reduced modulations of the N2-N450 amplitude in response to high vs. low cognitive control requirements. Yet, those effects could only be observed in methamphetamine users who had been abstinent for a relatively short time (mean 9.9; max. 18 months), but not in former users who had been abstinent two years or longer. While this finding alone does not allow for causal inferences, it suggests that the amelioration of control deficits may take longer than what is commonly investigated (1-6 months). Hence, some of the statements about permanent/irreversible dopamine-dependent executive dysfunctions in former methamphetamine users should be interpreted with caution.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abstinence; Cognitive control; Conflict monitoring; Methamphetamine; N2

Mesh:

Substances:

Year:  2018        PMID: 29953935     DOI: 10.1016/j.pnpbp.2018.06.015

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  11 in total

1.  Insights Into the Complexity of Methamphetamine Actions in the Brain and Periphery in the Face of a 3rd Methamphetamine Abuse Epidemic

Authors:  Anna Moszczynska
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

2.  Changes in ALFF and ReHo values in methamphetamine abstinent individuals based on the Harvard-Oxford atlas: A longitudinal resting-state fMRI study.

Authors:  Yanyao Du; Wenhan Yang; Jun Zhang; Jun Liu
Journal:  Addict Biol       Date:  2021-08-24       Impact factor: 4.093

3.  Inhibitory control failures and blunted cortisol response to psychosocial stress in amphetamine consumers after 6 months of abstinence.

Authors:  Yermein Benitez-López; Diego Redolar-Ripoll; Yaveth Ruvalcaba-Delgadillo; Fernando Jáuregui-Huerta
Journal:  J Res Med Sci       Date:  2019-03-25       Impact factor: 1.852

4.  The Role of DRD1 and DRD2 Receptors for Response Selection Under Varying Complexity Levels: Implications for Metacontrol Processes.

Authors:  Nicolas Zink; Wiebke Bensmann; Larissa Arning; Lorenza S Colzato; Ann-Kathrin Stock; Christian Beste
Journal:  Int J Neuropsychopharmacol       Date:  2019-12-01       Impact factor: 5.176

5.  Time perception deficits and its dose-dependent effect in methamphetamine dependents with short-term abstinence.

Authors:  Mingming Zhang; Di Zhao; Zhao Zhang; Xinyu Cao; Lu Yin; Yi Liu; Ti-Fei Yuan; Wenbo Luo
Journal:  Sci Adv       Date:  2019-10-30       Impact factor: 14.136

6.  Methamphetamine Users Show No Behavioral Deficits in Response Selection After Protracted Abstinence.

Authors:  Wiebke Bensmann; Julia Ernst; Marion Rädle; Antje Opitz; Christian Beste; Ann-Kathrin Stock
Journal:  Front Psychiatry       Date:  2019-11-19       Impact factor: 4.157

Review 7.  Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research.

Authors:  Alexandre A Guerin; Yvonne Bonomo; Andrew John Lawrence; Bernhard Theodor Baune; Eric J Nestler; Susan L Rossell; Jee Hyun Kim
Journal:  Front Psychiatry       Date:  2019-12-17       Impact factor: 4.157

8.  Neurocognitive Dysfunctions and Their Therapeutic Modulation in Patients With Methamphetamine Dependence: A Pilot Study.

Authors:  Nadine Bernhardt; Johannes Petzold; Cornelius Groß; Anna Scheck; Shakoor Pooseh; René Mayer-Pelinski; Ulrich S Zimmermann; Michael N Smolka; Maximilian Pilhatsch
Journal:  Front Psychiatry       Date:  2020-07-02       Impact factor: 4.157

9.  Parkin regulates drug-taking behavior in rat model of methamphetamine use disorder.

Authors:  Akhil Sharma; Arman Harutyunyan; Bernard L Schneider; Anna Moszczynska
Journal:  Transl Psychiatry       Date:  2021-05-17       Impact factor: 6.222

10.  Differential Responses of LINE-1 in the Dentate Gyrus, Striatum and Prefrontal Cortex to Chronic Neurotoxic Methamphetamine: A Study in Rat Brain.

Authors:  Anna Moszczynska
Journal:  Genes (Basel)       Date:  2020-03-28       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.